These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14624928)

  • 1. Prostate cancer in Klinefelter syndrome during hormonal replacement therapy.
    Hwang JJ; Dharmawardana PG; Uchio EM; Wynberg J; Phillips JL
    Urology; 2003 Nov; 62(5):941. PubMed ID: 14624928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer following testosterone replacement in Klinefelter syndrome.
    Bydder SA; Joseph DJ; Weinstein S; Stuckey BG
    ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone replacement therapy and prostate cancer: a word of caution.
    Brand TC; Canby-Hagino E; Thompson IM
    Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of testosterone replacement therapy in ageing men.
    Tan RS; Salazar JA
    Expert Opin Drug Saf; 2004 Nov; 3(6):599-606. PubMed ID: 15500418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate volume and growth during testosterone replacement therapy is related to visceral obesity in Klinefelter syndrome.
    Selice R; Caretta N; Di Mambro A; Torino M; Palego P; Ferlin A; Foresta C
    Eur J Endocrinol; 2013 Dec; 169(6):743-9. PubMed ID: 24001894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of testosterone replacement therapy on serum PSA in patients with Klinefelter syndrome.
    Shibasaki T; Sasagawa I; Suzuki Y; Yazawa H; Ichiyanagi O; Matsuki S; Miura M; Nakada T
    Arch Androl; 2001; 47(3):173-6. PubMed ID: 11695839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klinefelter syndrome with low gonadotropin levels.
    Cherian KE; Jebasingh FK; Kapoor N; Paul TV
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26715140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
    Rhoden EL; Morgentaler A
    J Urol; 2003 Dec; 170(6 Pt 1):2348-51. PubMed ID: 14634413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of testosterone replacement therapy in adolescents with Klinefelter syndrome.
    Mehta A; Clearman T; Paduch DA
    J Urol; 2014 May; 191(5 Suppl):1527-31. PubMed ID: 24679877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy and prostate cancer--safety concerns are well founded.
    Klotz L
    Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden.
    Arver S; Luong B; Fraschke A; Ghatnekar O; Stanisic S; Gultyev D; Müller E
    J Sex Med; 2014 Jan; 11(1):262-72. PubMed ID: 23937088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset hypogonadism: Prostate safety.
    Miranda EP; Torres LO
    Andrology; 2020 Nov; 8(6):1606-1613. PubMed ID: 32056383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
    Halland A; Jønler M; Pedersen KV
    Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy and prostate risks: where's the beef?
    Morgentaler A
    Can J Urol; 2006 Feb; 13 Suppl 1():40-3. PubMed ID: 16526980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone therapy in the ageing male: what about the prostate?
    Schultheiss D; Machtens S; Jonas U
    Andrologia; 2004 Dec; 36(6):355-65. PubMed ID: 15541051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism.
    Santella C; Renoux C; Yin H; Yu OHY; Azoulay L
    Am J Epidemiol; 2019 Sep; 188(9):1666-1673. PubMed ID: 31145457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
    Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD
    Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testosterone and the prostate].
    Sperling H; Rossi R; Lümmen G; Rübben H
    Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.